Physician profile
Vera Malezhik
NPI 1134547243
$3,889.38
in general payments reported to CMS, 2019-2025
18 companies · $819 in 2025
The $819 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $183 · 2021: $449 · 2022: $898 · 2023: $649 · 2024: $573 · 2025: $819.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,899.58 | 2019-2025 | Augment Injectable, Prostep Mica, Citrefix |
| Medtronic, INC. | $323.24 | 2022-2023 | Mazor X System |
| Horizon Therapeutics Plc | $202.00 | 2019-2021 | |
| Nevro Corp. | $191.76 | 2022 | |
| Djo, LLC | $168.04 | 2023-2025 | Cmf |
| Globus Medical, INC. | $152.94 | 2025 | Senza |
| Amgen INC. | $150.00 | 2024 | Krystexxa |
| Medline Industries LP | $147.41 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $146.12 | 2021 | |
| Grt US Holding, INC. | $145.21 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $86.43 | 2023-2025 | Nuzyra |
| Paragon 28, INC. | $75.31 | 2021-2025 | Mtp |
| Bioventus LLC | $58.20 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $41.80 | 2021 | |
| Treace Medical Concepts, INC. | $38.49 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sebela Pharmaceuticals INC. | $33.21 | 2020-2021 | |
| Sandoz INC. | $15.35 | 2021 | |
| Melinta Therapeutics, LLC | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vera Malezhik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.